Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs

Leeds & North Yorkshire
18 September 2014 17:10



London
18 September 2014 16:24



Sussex, Surrey
18 September 2014 16:06


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+441494 818 049

Testimonials
I was really impressed with the recruitment experience which Zenopa provided. Initially meeting with them face to face was important as we could gage which roles would be right for me.
Daniel , 2013

UK infectious disease research funding 'neglecting key areas'

7 November 2012 15:50 in Scientific Developments/Breakthroughs


A new British study has highlighted flaws and oversights in the way infectious disease research funding is allocated in the UK.

The University College, Imperial College and the London School of Hygiene and Tropical Medicine paper revealed that studies into diseases that result in high rates of death and disability do not currently receive enough support.

Of the 2.6 billion pounds invested in this area between 1997 and 2010, only 254 million pounds went towards gastrointestinal diseases, despite these being estimated to account for 22.2 percent of deaths due to infectious disease in 2004.

Similarly, antimicrobial resistance and tropical diseases such as trachoma were also shown to receive relatively low levels of investment from UK funding bodies.

The study's senior author Professor Rifat Atun, of Imperial College London, said: "Prioritisation of research funding, especially from public sources, must follow transparent criteria to ensure funding is fair and in line with the current and emerging problems faced by the UK and the global community."

UK organisations that aim to enhance the country's status as a centre for disease research include the Wellcome Trust and Medical Research Council, which invested 13 million pounds towards creating a new national stem cell resource earlier this week.ADNFCR-8000103-ID-801483886-ADNFCR

Other news stories from 07/11/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd